Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology
Volume 26, Issue 7, Pages 429-435
http://dx.doi.org/10.1155/2012/928912
Original Article

Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study

Yasmine Yousef,1 Kathie Béland,1 Emmanuel Mas,2 Pascal Lapierre,1 Dorothée Bouron Dal Soglio,3 and Fernando Alvarez1,4

1Division of Gastroenterology, Hepatology and Nutrition, CHU Sainte-Justine, Montreal, Quebec, Canada
2Division of Gastroenterology, Hepatology, Nutrition and Diabetology, Children’s Hospital, Toulouse, France
3Division of Pathology, CHU Sainte-Justine, Canada
4Department of Paediatrics, University of Montreal, Montreal, Quebec, Canada

Received 27 June 2011; Accepted 12 October 2011

Copyright © 2012 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yasmine Yousef, Kathie Béland, Emmanuel Mas, Pascal Lapierre, Dorothée Bouron Dal Soglio, and Fernando Alvarez, “Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study,” Canadian Journal of Gastroenterology, vol. 26, no. 7, pp. 429-435, 2012. https://doi.org/10.1155/2012/928912.